SUCLEAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Suclear, and when can generic versions of Suclear launch?
Suclear is a drug marketed by Braintree Labs and is included in one NDA.
The generic ingredient in SUCLEAR is magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate. There are one hundred and forty-six drug master file entries for this compound. Additional details are available on the magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUCLEAR?
- What are the global sales for SUCLEAR?
- What is Average Wholesale Price for SUCLEAR?
Summary for SUCLEAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | SUCLEAR at DailyMed |
US Patents and Regulatory Information for SUCLEAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Braintree Labs | SUCLEAR | magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate | SOLUTION;ORAL | 203595-001 | Jan 18, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
